You Position: Home > Paper

Intension and extension of minimal residual disease in acute leukemia

( views:0, downloads:0 )
Author:
No author available
Journal Title:
Journal of Leukemia and Lymphoma
Issue:
1
DOI:
10.3760/cma.j.cn115356-20221019-00304
Key Word:
白血病,急性;微小残留病;恶性血液病;恶性肿瘤;个体化治疗;Leukemia, acute;Minimal residual disease;Hematological malignancies;Malignant tumor;Individualized therapy

Abstract: Minimal residual disease (MRD) has been used not only for relapse prediction, prognosis re-classification and directing pre-emptive therapy of patients with acute leukemia, but also in the field of therapy for patients with other hematological malignancies or solid tumors. A deep understanding of the intension and extension of MRD is important for exploring novel methods for accurate prediction of relapse and consummating the individualized intervention strategies for malignant tumors.

  • This article has no references!
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn